Rapalogix Health
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $19M
Investors
- 2
About Rapalogix Health
Based in the US, Rapalogix Health, Inc. delivers advanced dermatology therapeutics and skincare solutions, utilizing mTOR science to combat skin aging and disease effectively.Rapalogix Health, Inc. focuses on innovative dermatological solutions, having been founded in 2024 by Rahul Mehta, PhD (Co-Founder & CEO), Doris Day, MD (Co-Founder), Brent Saunders (Co-Founder), and James Peyer, PhD (Co-Founder and Board Chair) in the US. The founder's experience or any previous ventures are not disclosed. Rapalogix specializes in innovative dermatology therapeutics and skincare solutions, leveraging advanced mTOR science to address fundamental biological causes of skin aging and disease. Core offerings include therapeutic products for dermatologic conditions linked to TORC1 dysregulation and professional skincare products designed to enhance skin balance and vitality. The company serves dermatologists, skincare professionals, and end consumers, focusing primarily on North America and Europe. Rapalogix generates revenue through a blend of direct-to-consumer sales and partnerships with healthcare professionals and retailers. Its proprietary skincare products are tailored to address specific skin health issues, available individually or as part of curated skincare regimens. Pricing reflects the premium nature of the products, emphasizing their scientific foundation and efficacy while fostering long-term relationships with clients through education and clinical support. In June 2026, Rapalogix Health, Inc. The company aims to expand its product line by designing new dermatology therapeutics and skincare solutions, although specific release dates are not provided. Geographically, Rapalogix targets expansion into additional regions in North America and Europe to broaden its market reach.
Who invested in Rapalogix Health
2 investors across 1 round
See all investors in Rapalogix Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 22, 2026
Amount
$19M
Investors
Questions about Rapalogix Health
Who invested in Rapalogix Health?
Rapalogix Health has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rapalogix Health raised?
Rapalogix Health has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rapalogix Health last raise money?
Rapalogix Health's most recent round on record is a Series A, in Jun 2026.
What does Rapalogix Health do?
Based in the US, Rapalogix Health, Inc.
Where is Rapalogix Health headquartered?
Rapalogix Health is headquartered in New York, US.
Which VCs invest in companies like Rapalogix Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rapalogix Health's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rapalogix Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.